ProjMed article archive
Every ProjMed story ships with clinician, investor, and patient lenses; ELI5 and regulatory depth; and an evidence grade.
Ultra-Processed Foods: Disagreement on Health Impact Beyond Nutrient Content
While evidence links ultra-processed foods (UPFs) to adverse health outcomes, experts differ on whether the processing itself or merely their high fat, sugar, and salt content is the primary driver of risk.
Closing the Epilepsy Treatment Gap: Why Stigma and Access Undermine Innovation
Despite significant progress in antiepileptic drugs and device therapies, a substantial portion of epilepsy patients globally remain untreated or inadequately managed, often due to social stigma and systemic healthcare access issues rather than a lack of medical solutions.
UK Advisors Recommend Routine Meningitis B Vaccination for 15-Year-Olds After Outbreak
The shift in guidance from the Joint Committee on Vaccination and Immunisation follows a significant Meningitis B outbreak in Kent and growing evidence of increased risk in socially active adolescents.
Tinnitus Management: Navigating a Fragmented Device Landscape
Recent advances in tinnitus treatment emphasize combination therapies and neuromodulation, yet sustained relief remains an elusive goal for many patients, highlighting the need for more robust clinical evidence.
Oral Semaglutide vs. Injectable: Navigating UK Weight Loss Prescribing Landscape
Regulatory differences and reimbursement strategies in the UK are shaping the availability and adoption of oral and injectable GLP-1 receptor agonists for weight management, with implications for patient access and market dynamics.